FilingReader Intelligence
Haohai Biological Technology completes board reshuffle, outlines 2024 plans
June 10, 2025 at 05:12 PM UTC•By FilingReader AI
Shanghai Haohai Biological Technology (SSE:688366) has announced the successful completion of its board reshuffle at the 2024 Annual General Meeting, alongside key decisions regarding leadership, committee appointments, and financial planning. The company has elected its sixth board, with key figures like Hou Yongtai continuing as Chairman. Alongside the leadership transition, the meeting addressed critical strategic elements.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Announcement of Shanghai Haohai Biotechnology Co., Ltd. on the completion of the board of directors' election and appointment of senior management and securities affairs representativesJune 10, 2025 at 08:00 AM UTC
Announcement of Resolutions of Shanghai Haohai Biotechnology Co., Ltd.'s 2024 Annual General Meeting of Shareholders, 2025 First A Shareholders' Class Meeting and 2025 First H Shareholders' Class MeetingJune 10, 2025 at 08:00 AM UTC
Announcement of Shanghai Haohai Biotechnology Co., Ltd. on Adjustment of the Total Cash Dividends for Profit Distribution in 2024June 10, 2025 at 08:00 AM UTC
Announcement of Shanghai Haohai Biotechnology Co., Ltd. on the election of employee representative directors of the sixth board of directorsJune 10, 2025 at 08:00 AM UTC
SSE:688366•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Shanghai Haohai Biological Technology publishes news
Free account required • Unsubscribe anytime